DBPR-108

SynDRA canonical compound SYN0022278 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	DPP4
Mechanism of action	dipeptidyl peptidase inhibitor

All known targets

DPP4

Mechanisms of action (all sources)

DPP4 inhibitor

Cross-references

PubChem CID: 44201003
ChEMBL: CHEMBL1082462
DrugBank: DB20606
Wikipedia: Prusogliptin
LINCS BRD: BRD-K83020231

Synonyms

Prusogliptin
RefChem:131050
DBPR108
E329HG23ZT
UNII-E329HG23ZT
MFCD28385883
Shan Zeping (China)
Prusogliptin [WHO-DD]
PRUSOGLIPTIN [INN]
orb1308401
SCHEMBL2401277
C16H25FN4O2
GTPL14396
VQKSCYBKUIDZEI-STQMWFEESA-N
GLXC-90520
LXB42666
BDBM50320120
AKOS030526298
CS-3825
NCGC00485889-01
DA-62704
HY-12528
MS-24846
D83651
T15079
BRD-K83020231-001-01-2
prusogliptin
پروسوگلیپتین

Look up DBPR-108 in the interactive SynDRA portal →